Neurofilament levels in late preterm newborns
Part of Women’s health & pregnancy clinical trials.
This study looks at a substance in the blood called neurofilaments, which may help doctors understand early brain development in babies born a few weeks early. If your baby already needs a blood test, researchers will use a small extra sample to learn more.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your baby was born between 34 and 37 weeks of pregnancy.
- Your baby already needs a blood test for another medical reason.
- You, as a parent, can give signed permission for the study.
- Your baby does not have any known brain or nerve disorders.
- Your baby does not have serious birth defects.
- There is no medical reason preventing a blood draw.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study collects health information and biological samples from very premature babies to understand what affects their development. It may help researchers find ways to improve care and outcomes for infants like yours.
This study collects blood samples and health information from healthy full-term newborns to establish normal ranges for brain-related markers in early life. Understanding these baseline levels may help doctors better identify babies who need extra care in the future.
This trial is checking if certain proteins in your blood (called placental growth factor and nucleosomes) during early pregnancy can help predict problems like preeclampsia or preterm birth. If you join, you'll give a blood sample during your regular NIPT test, and researchers will follow your pregnancy to see how it goes.
This pilot study looks at tiny particles in blood (microvesicles) to learn how they differ in women with threatened preterm delivery, with or without pre-eclampsia. Results may help doctors better identify risk and improve care for early delivery.
This study tests whether different caregivers get the same results when they observe very premature babies using a special scale. It may help improve how we measure development in early-born infants.
This study looks at a blood test done early in pregnancy (NIPT) to see if it can help predict conditions like preeclampsia, preterm labor, or gestational diabetes. If you had this test and had a healthy pregnancy or one of these complications, you may be able to join.
Hear when a new Healthy Participants trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.